Abstract

This comprehensive update explores the recent advancements in the treatment
landscape of myeloid leukemia. Myeloid leukemia, a heterogeneous group of
hematological malignancies, poses significant challenges in clinical management.
This review highlights the latest therapeutic approaches, including targeted
therapies, immunotherapies, and emerging treatment modalities. It discusses the
impact of precision medicine, novel drug developments, and the evolving role of
immunotherapy in managing myeloid leukemia. Furthermore, the abstract outlines
current research trends, challenges, and future prospects, aiming to provide a
concise overview for healthcare professionals and researchers involved in leukemia
management.
Keywords: targeted therapy; immunotherapy; precision medicine; molecular
profiling; personalized treatment; bone marrow transplantation; novel therapies